Literature DB >> 18305456

Contingency management: utility in the treatment of drug abuse disorders.

M L Stitzer1, R Vandrey.   

Abstract

Contingency management (CM) is a strategy that uses positive reinforcement to improve the clinical outcomes of substance abusers in treatment, especially sustained abstinence from drugs of abuse. Further, CM has been adopted to improve methodology and interpretation of outcomes in clinical trials testing new pharmacotherapies and to improve adherence to efficacious medications in substance abuse patients. Thus, CM has proven to be widely useful as a direct therapeutic intervention and as a tool in treatment development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305456     DOI: 10.1038/sj.clpt.6100508

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  25 in total

Review 1.  Interventions to Reduce Drug Use Among Methamphetamine Users at Risk for HIV.

Authors:  Karen F Corsi; Steve Shoptaw; Musheng Alishahi; Robert E Booth
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

Review 2.  Implementation of evidence-based substance use disorder continuing care interventions.

Authors:  Steven J Lash; Christine Timko; Geoffery M Curran; James R McKay; Jennifer L Burden
Journal:  Psychol Addict Behav       Date:  2011-06

3.  Technology-Based Contingency Management in the Treatment of Substance-Use Disorders.

Authors:  Jesse Dallery; Bethany R Raiff; Michael J Grabinski; Lisa A Marsch
Journal:  Perspect Behav Sci       Date:  2019-07-09

Review 4.  Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.

Authors:  Gen Kanayama; Kirk J Brower; Ruth I Wood; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2010-02-25       Impact factor: 4.492

5.  A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users.

Authors:  Randi Melissa Schuster; Ailish Hanly; Jodi Gilman; Alan Budney; Ryan Vandrey; A Eden Evins
Journal:  Drug Alcohol Depend       Date:  2016-08-28       Impact factor: 4.492

6.  Cocaine-induced suppression of saccharin intake and morphine modulation of Ca²⁺ channel currents in sensory neurons of OPRM1 A118G mice.

Authors:  Christopher S Freet; Sarah M Ballard; Danielle N Alexander; Taylor A Cox; Caesar G Imperio; Nnaemeka Anosike; Alyssa B Carter; Saifeldin Mahmoud; Victor Ruiz-Velasco; Patricia S Grigson
Journal:  Physiol Behav       Date:  2014-11-18

Review 7.  Can money prevent the spread of HIV? A review of cash payments for HIV prevention.

Authors:  Audrey Pettifor; Catherine MacPhail; Nadia Nguyen; Molly Rosenberg
Journal:  AIDS Behav       Date:  2012-10

8.  Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial.

Authors:  Marc E Mooney; David V Herin; Joy M Schmitz; Nidal Moukaddam; Charles E Green; John Grabowski
Journal:  Drug Alcohol Depend       Date:  2008-12-05       Impact factor: 4.492

Review 9.  Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside.

Authors:  Steven M Graves; Roueen Rafeyan; Jeffrey Watts; T Celeste Napier
Journal:  Pharmacol Ther       Date:  2012-08-29       Impact factor: 12.310

Review 10.  Integrated treatment of substance use and psychiatric disorders.

Authors:  Thomas M Kelly; Dennis C Daley
Journal:  Soc Work Public Health       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.